The IRE1-XBP1 signalling pathway is part of a cellular programme that protects against endoplasmic reticulum (ER) stress, but also controls development and survival of immune cells. Loss of XBP1 in splenic type 1 conventional dendritic cells (cDC1s) results in functional alterations without affecting cell survival. However, in mucosal cDC1s, loss of XBP1 impaired survival in a tissue-specific manner-while lung cDC1s die, intestinal cDC1s survive. This was not caused by differential activation of ER stress cell-death regulators CHOP or JNK. Rather, survival of intestinal cDC1s was associated with their ability to shut down protein synthesis through a protective integrated stress response and their marked increase in regulated IRE1-dependent messenger RNA decay. Furthermore, loss of IRE1 endonuclease on top of XBP1 led to cDC1 loss in the intestine. Thus, mucosal DCs differentially mount ATF4-and IRE1-dependent adaptive mechanisms to survive in the face of ER stress.
X-box binding protein-1 (XBP1) is a transcription factor activated by inositol-requiring enzyme-1 (IRE1), a transmembrane protein residing in the endoplasmic reticulum (ER), with kinase and endonuclease activity. Upon activation, IRE1 oligomerizes and transphosphorylates neighbouring IRE1 molecules, engaging its endonuclease activity. This results in an unusual splicing of the Xbp1 messenger RNA and allows translation of the active XBP1s (refs [1] [2] [3] .
The IRE1-XBP1 axis is part of the unfolded protein response (UPR) that monitors and maintains the fidelity of the cellular proteome. The UPR comprises two additional transmembrane sensors named activating transcription factor 6 (ATF6) and protein kinase RNA-like endoplasmic reticulum kinase (PERK) 1 . Physiological and pathophysiological perturbations (for example, viral infections, hypoxia or nutrient deprivation) can overwhelm ER folding capacity, resulting in the accumulation of misfolded proteins, a condition referred to as ER stress. By increasing folding capacity, enhancing misfolded protein degradation and inhibiting protein translation, the UPR sensors cooperatively orchestrate the recovery of ER homeostasis 4 .
When unabated, ER stress often results in cell death, and multiple apoptotic pathways originate from the UPR 5 . Downstream of PERK, CHOP is a transcriptional regulator that induces cell death by several mechanisms 6, 7 . Through the upregulation of the phosphatase GADD34, the ATF4-CHOP branch modulates eIF2α phosphorylation, which allows ER stressed cells to resume protein synthesis. This is considered a crucial checkpoint in determining cell survival during unresolved ER stress 8 . The IRE1 sensor can also trigger cell death. During severe ER stress IRE1 endonuclease substrate specificity broadens, causing additional ER-localized RNAs to be cleaved in a process referred to as regulated IRE1-dependent decay of RNA (RIDD) 9, 10 . Although this might embody an adaptive mechanism to reduce ER client proteins initially, RIDD has also been shown to trigger a proapoptotic response [11] [12] [13] . Dendritic cells (DCs) are the sentinels of the immune system, which sample tissue-derived antigens, migrate to the draining lymph nodes (LNs) and present antigens to naive T-cells, inducing cellular immunity. Transcriptional profiling and ontogeny studies have identified two types of conventional DC (cDC1s and cDC2s) and plasmacytoid DCs, each with specialized function [14] [15] [16] [17] . We previously reported that splenic cDC1s constitutively splice XBP1, independently of canonical UPR activation 18 . Furthermore, deletion of XBP1 in this splenic subset resulted in disturbed ER architecture, decreased expression of the integrin CD11c and a crippled ability to cross-present dead cell-associated antigens, but without affecting cell survival 18 .
In the present study, we analysed the function of XBP1 and UPR in the cDCs that reside in the lung and gut mucosa. In marked contrast to splenic cDCs, conditional deletion of XBP1 in CD11c
+ cells resulted in a profound and cell-intrinsic loss of lung cDC1s, caused by apoptosis. Unexpectedly, intestinal cDC1s did not succumb to XBP1 deficiency. In these cells, survival was associated with an eIF2α-and 4E-BP1-dependent protein translation inhibition and a pronounced activation of RIDD. Loss of RIDD on top of XBP1 by compound deficiency caused cDC1 cell death also in the intestine. We conclude that IRE1 endonuclease activity sets the threshold for cDC1 survival in the face of ER stress.
RESULTS

Spontaneous IRE1 activation in cDC1s is tissue dependent
It was previously shown that DCs, specifically cDC1s derived from the spleen 18 , display high basal XBP1 splicing activity 19, 20 . Using the ERAI mouse strain, which reports on IRE1 endonuclease activity, we investigated if constitutive XBP1 splicing was conserved across different tissues and subsets of DCs. Staining with XCR1 and CD172 (Sirpα) readily identified cDC subsets in spleen and peripheral organs, as confirmed by CD103 and CD11b expression ( Fig. 1a and Supplementary Fig. 1a ). Using this universally applicable gating strategy 21 , we found that DCs expressed higher levels of VenusFP than other immune cells (Fig. 1b,c) . Compared with cDC2s, cDC1s displayed the brightest VenusFP fluorescence throughout the different organs. A notable exception were lung-derived cDC1s, which showed similar VenusFP expression to CD24 + cDC2s (ref. 22) (Fig. 1b,c ). IRE1 endonuclease activity in ERAI mice closely correlated with IRE1 protein expression levels in cDC1s in different tissues (Fig. 1d) . Thus, high basal activation of the IRE1 endonuclease is conserved among cDC1s, which is strongly dependent on the tissue of residence.
XBP1 deletion affects mucosal cDCs differentially
To gain insights regarding the tissue-specific regulation of XBP1 splicing in DCs, we used Itgax-Cre (Cd11c-Cre) × Xbp1 fl/fl mice, referred to as XBP1 DC mice 18 . In these mice, we reported that splenic cDC1s express markedly low levels of the integrin CD11c, caused by RIDD-dependent degradation of mRNA encoding CD18, an obligate dimeric partner of CD11c (ref. 18) . Therefore, CD11c cannot be used as a universal lineage marker for cDC identification in XBP1 DC mice. By applying a new gating strategy to define DC lineages independently of CD11c ( Supplementary Fig. 2a ), we confirmed that absence of XBP1 did not affect splenic cDC1 and cDC2 numbers (Fig. 2a ), yet selectively decreased CD11c expression (ref. 18 and Supplementary Fig. 2b ).
Next, we analysed the lung and lung-draining mediastinal (Med) LNs of XBP1 DC mice and control littermates. While lung cDC2s remained unaffected in XBP1 DC mice, cDC1s were reduced by half (Fig. 2b) . Additional cells in which the Cre recombinase is active in Itgax-Cre mice were normally present in the lung of XBP1 DC mice, with the exception of a small decrease of alveolar macrophages ( Supplementary Fig. 2c,d ). The selective reduction of lung cDC1s in XBP1 DC mice was not caused by a maturation defect, as expression of MHCII and the costimulatory molecule CD86 remained unaltered in the absence of XBP1 ( Supplementary Fig. 2e ). In the LNs, the differential expression of CCR7 and MHCII allows the discrimination of 'LN-resident' cDCs, and migratory cDCs that traffic to the LN from non-lymphoid tissue 15 . Migratory CCR7 hi MHCII hi cDC1s in MedLN were strongly reduced in XBP1 DC mice. The frequency of migratory cDC2s was slightly increased (Fig. 2c) . Analogous to splenic cDCs (ref. 18 ), loss of XBP1 did not alter frequencies of CCR7 lo lymphoid-resident cDC1s or cDC2s (Fig. 2d) . Altogether, these findings indicate that XBP1 selectively regulates the homeostasis of tissue-resident and migratory lung cDC1s, but not cDC2s.
In contrast to the lung, cDCs of the lamina propria of the small intestine (LP-SI) were largely unaffected by loss of XBP1 (Fig. 2e ). There was a minor trend to fewer migratory cDC1s in the mesenteric (Mes) LN. Again, the frequency of migratory cDC2s was increased (Fig. 2f) , while resident cDCs of MesLN were also unaffected (Fig. 2g) . All examined cDC1 populations demonstrated signs of XBP1 deletion, as reflected by selective reduction in surface expression of CD11c ( Fig. 2h and Supplementary Fig. 2b ) and loss of Xbp1 exon 2 mRNA ( Supplementary Fig. 2f ). These data indicate that XBP1 deficiency selectively affects the homeostasis of tissue-resident cDC1s in the lung but not in the intestine or spleen.
Absence of XBP1 causes cell-intrinsic loss of lung cDC1s
DCs communicate extensively with their environment, which may lead to niche-specific cellular differentiation programs that could be disturbed in XBP1 DC mice. To address the contribution of defects in DC microenvironment, we generated bone marrow (BM) chimaeric mice by injecting lethally irradiated CD45.1/2 mice with a mixture of BM cells of CD45.1 wild-type (WT) and CD45.2 XBP1 DC origin (Fig. 2i ). CD45.2 XBP1 DC and CD45.1 WT BM cells equally repopulated neutrophil and splenic DC populations (Fig. 2j) . In contrast, lung cDC1s from XBP1 DC BM failed to compete with WT cells (Fig. 2k) . Similarly, MedLN migratory cDC1 ratios were reduced in the absence of XBP1. In the more stringent competitive setting of BM chimaerism, we also noted a small disadvantage for XBP1-deficient cDC2s to repopulate the lung; however, this effect was no longer observed for MedLN migratory cDC2s. Loss of XBP1 minimally affected MedLN resident cDC1 and cDC2 ratios (Fig. 2k) , indicating that XBP1 selectively regulates lung-derived cDC1 homeostasis.
The composition of the DC network in LP-SI and MesLN from the BM chimaeras remained largely unaffected, aside from a minor but statistically significant defect in the intestinal cDC1 population (Fig. 2l) . Therefore, we conclude that the selective loss of lung cDC1s in XBP1 DC mice is cell intrinsic and cannot be explained by additional deficiencies in the immune system or tissue environment.
XBP1-deficient cDC1s develop normally
XBP1 is implicated in the differentiation of secretory cells including hepatocytes 23 , acinar cells 24 , Paneth cells 25 and plasma cells 26 , but also of non-secretory cells such as eosinophils 27 . To address whether XBP1 regulates DC development, we monitored VenusFP fluorescence in ERAI transgenic DC precursors. Using Siglec-H and Ly6C to identify . Kruskal-Wallis test with Dunn's multiple comparisons: * P < 0.05; * * * * P < 0.001. Data are representative of three independent experiments. Source data for d can be found in Supplementary  Table 2. dedicated cDC1 and cDC2 pre-DC populations 28 , we found that only splenic pre-cDC1s (identified as Siglec-H − , Ly6C − ) but not BM precDC1s or cDC2 precursors (Siglec-H − , Ly6C + ) expressed VenusFP ( Fig. 3a and Supplementary Fig. 3a) . Splenic pre-cDC1s also express CD24 (ref. 29) , and this CD24 high pre-DC population displayed VenusFP fluorescence, suggesting that XBP1 splicing defines the cDC1 lineage (Fig. 3a) . To assess commitment of VenusFP + precursors into cDC1s, splenic pre-DCs were sorted based on VenusFP expression and cultured ex vivo. After 24 h of culture, VenusFP + pre-DCs yielded mainly XCR1 + cDC1s (Fig. 3b) . No subpopulation of earlier progenitor cells in the BM expressed high levels of VenusFP protein (Fig. 3a,c and Supplementary Fig. 3b ), indicating that activation of IRE1 in pre-cDC1s is a late event in the commitment towards the cDC1 lineage.
To address the contribution of XBP1 to pre-DC homeostasis, we analysed the previously established BM chimaeric mice (Fig. 2i) . . Mann-Whitney test, * P < 0.05; * * P < 0.01; * * * * P < 0.001. Data were pooled across two experiments (c,d,f,g) or represent at least three similar experiments (a,b,e,h,j-l). Siglec-H -Ly6C -pre-DCs . Kruskal-Wallis test with Dunn's multiple comparisons, * * P < 0.01; * * * * P < 0.001. Data are representative of two (a-e) similar experiments or pooled across two independent experiments (f). Source data for a,b,e can be found in Supplementary Table 2 .
Ratio
Pre-DC ratios were similar in spleen, lung and intestine, arguing against an effect of XBP1 deficiency at the pre-DC stage (Fig. 3d) . Alternatively, DC precursors from XBP1 DC mice could be skewed to cDC2 development. To address this, sorted pre-DCs from CD45.1 WT and CD45.2 XBP1 DC mice were differentiated ex vivo. Although ex vivo differentiated DCs efficiently recombined the Xbp1 allele ( Supplementary Fig. 3c ), CD45.1 WT and CD45.2 XBP1 DC preDCs gave rise to equal proportions of cDC1s and cDC2s (Fig. 3e) , indicating that XBP1 loss does not alter pre-DC differentiation. Furthermore, expression of key transcription factors required for lung cDC1 development was unaffected by XBP1 deficiency 15 ( Supplementary Fig. 3d ).
Finally, to formally exclude a role for defective DC development in the loss of lung cDC1s, we made use of an alternative Cre line (CD11c-Cre-eGFP mice) that recombines floxed alleles only in terminally differentiated cDCs, excluding pre-DCs (ref. 30 and validated in Supplementary Fig. 3e ). Similarly to the XBP1 DC mice, the Xbp1 fl/fl × Cd11c-Cre-eGFP mice (XBP1 DC-Late) displayed a profound loss of lung cDC1s (Fig. 3f) . Altogether, these data indicate that XBP1 loss does not affect cDC1 development.
Loss of XBP1 induces apoptosis in lung cDC1s
Pre-DCs proliferate before differentiation into DCs (refs 28,29,31) . Arguing against a role for defective replication, expression of the proliferation marker Ki67 was not reduced, but rather increased in XBP1-deficient lung cDC1s (Fig. 4a ). This was confirmed by 5-bromodeoxyuridine (BrdU) staining (Fig. 4b ), indicating that reduced proliferation was not the cause of the lung cDC1 loss.
The increased BrdU uptake could indicate a compensatory mechanism to replenish dying cDC1s. To address whether XBP1 DC cDC1s are more prone to cell death, lung or intestinal cDCs of CD45.2 XBP1 DC or CD45. survival of lung cDC2s and cDCs from the intestine remained largely unaltered (Fig. 4c) . Indicative of enhanced apoptosis, the Annexin V-negative (Ann-V − ) population was reduced in ex vivo cultured XBP1 DC lung cDC1s when compared with Xbp1 fl/fl counterparts ( Supplementary Fig. 4a ). Indeed, zVAD-fmk, a pan-caspase inhibitor, rescued cDC1s isolated from XBP1 DC mice ( Fig. 4d and Supplementary Fig. 4a ). zVAD-fmk treatment did not alter the ratios of Ann-V − lung cDC2s or intestinal cDCs ( Supplementary Fig. 4b ). These data indicate that XBP1-deficient lung cDC1s succumb to apoptosis, whereas intestinal cDC1s defy XBP1 loss.
ER stress-induced death of cDC1 is CHOP and JNK independent
As loss of XBP1 causes ER stress in some-but not all-cell types, and irremediable ER stress is known to trigger apoptosis 5, 18 , we investigated whether distinct degrees of ER stress in lung and intestinal cDC1s of XBP1 DC mice might result in different cell fates. Immunostaining for KDEL-containing proteins and transmission electron microscopy revealed comparable aggregates of tubular ER in lung and intestinal cDC1s, a hallmark of XBP1 deficiency in splenic cDC1s (ref. 18) (Fig. 5a and Supplementary Fig. 5a ). cDC2s were largely devoid of these structures ( Supplementary Fig. 5b ). Furthermore, expression of ER stress target genes (Hspa5, Herpud, Atf4, Ddit3 and Trib3) appeared similar in lung and intestinal cDC1s ( Fig. 5b and Supplementary Fig. 5f ). Thus, lung and intestinal cDC1s from XBP1 DC mice displayed similar signs of ongoing ER stress.
CHOP (encoded by Ddit3) is the best known executor of ER stressmediated apoptosis 5 . As Ddit3 was induced ( Fig. 5b and reported in ref. 18 ), we generated transgenic mice deficient for both XBP1 and CHOP in DCs (Supplementary Fig. 5c ). Nonetheless, CHOP deletion did not restore lung or migratory MedLN cDC1s (Fig. 5c,d ), suggesting that loss of lung cDC1s by XBP1 deficiency was not due to CHOP activation.
A second branch of ER stress-induced apoptosis is controlled by IRE1-mediated JNK activation 25, 32 . Immunoblotting confirmed enhanced JNK phosphorylation in XBP1-deficient splenic cDC1s (Supplementary Fig. 5d and Supplementary Fig. 8 ). When XBP1 DC mice were treated with CC-930, a specific inhibitor of JNK phosphorylation (ref. 33 and validated in Supplementary Figs 5e and 8), there was no rescue of lung cDC1s or migratory MedLN counterparts (Fig. 5e,f) . On the contrary, JNK inhibition resulted in remarkably fewer migratory MedLN cDC1s.
Together, XBP1-deficient cDC1s displayed robust activation of the remaining UPR branches, but execution of apoptosis of lung cDC1s was not dependent on CHOP or JNK activation ( Supplementary Fig. 5f ).
Regulation of protein translation and integrated stress response in cDCs
Although lung and intestinal cDC1s experience similar degrees of ER stress (Fig. 5a,b) , discrete differences in adaptive responses might explain the distinct cell fates. Translation inhibition and reduction of the ER client protein load by PERK-mediated phosphorylation of eIF2α is a crucial adaptive mechanism for cell survival in conditions of ER stress 34 . To investigate this, we used O-propargyl-puromycin (OP-puro) incorporation into nascent polypeptides to measure translation in vivo 35 . This protocol faithfully reports on translational rate, as shown by reduced fluorescence in the presence of translation inhibitors (ref. 35 and Supplementary Fig. 6a ). To monitor the effects of XBP1 deficiency on protein synthesis in a cell-intrinsic manner, OP-puro was injected into CD45.2 XBP1 DC/CD45.1 WT chimaeric mice (Fig. 2l) . Compared with other immune cells, cDC1s incorporate 
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MedLN mig. cDC1s very high quantities of OP-puro ( Fig. 6a and Supplementary Fig. 6b ). Intestinal XBP1-deficient cDC1s showed reduced translational rate, 70% of that of the WT counterparts. In contrast, lung cDC1s displayed no difference in translation upon XBP1 loss (Fig. 6a) .
Several mechanisms could account for the reduced translation in cDC1s, including eIF2α phosphorylation. Despite decreasing global translation, the presence of phosphorylated eIF2α also enhances translation of distinct mRNAs containing upstream open reading frames in their 5 untranslated regions, such as activated transcription factor (ATF)4 (ref. 36 and Supplementary Fig. 6h ). ATF4 regulates the integrated stress response (ISR), preparing cells for enhanced amino-acid uptake, protein synthesis and folding capacity by inducing mRNAs for antioxidant response (Mtfhd2, Sesn2, Chac1) and aminoacid metabolism (Mars, Asns, Shmt2, Gpt2) (ref. 36 and Supplementary  Fig. 6h ). In contrast to lung cDC1s, several ISR genes were more strongly induced in intestine-derived cDC1s in the absence of XBP1 (Fig. 6b) . Unexpectedly, despite the ATF4-dependent gene signature, phosphorylation of eIF2α in XBP1-deficient intestinal cDC1s was markedly reduced (Fig. 6c and Supplementary Fig. 6c ). This correlated with an enhanced expression of the ATF4 target Gadd34 (Ppp1r15a) mRNA in intestinal cDC1s (Fig. 6d) . This inducible phosphatase reduces eIF2α phosphorylation during ER stress and establishes a negative feedback loop, restoring protein translation [37] [38] [39] . Lung cDC1s did not regulate phosphorylation of eIF2α (Fig. 6c) .
Translational control in DCs can occur in an eIF2α-independent manner, although the underlying mechanism remains unclear 40 . Unable to explain the sustained inhibition of translation in intestinal cDC1s in the absence of eIF2α phosphorylation, we examined 4E-BP1, a second node of translational control 41, 42 . 4E-BP1 is an ISR gene expressed during chronic ER stress 43 . Inhibiting Relative RNA expression LP-SI cDC1s * * eIF4F assembly, 4E-BP1 inhibits cap-dependent translation while promoting translation of select mRNAs containing internal ribosome entry sites (IRESs) 41 . In contrast to lung cDC1s, intestinal cDC1s accumulated higher levels of 4E-BP1 in the absence of XBP1 (Fig. 6e) . Phosphorylation, which inhibits 4E-BP1 (ref. 44) , was lower in intestinal cDC1s when compared with lung cDC1s, irrespective of XBP1 (Supplementary Fig. 6d ). Indicative of ongoing IRES-mediated translation, death-associated protein DAP5, containing a known IRES in its mRNA 41 , was enhanced in the absence of XBP1 in intestinal but not in lung cDC1s (Supplementary Fig. 6e ).
ISRIB, a compound that renders cells insensitive to eIF2α phosphorylation 45 , allowed us to examine the role of the ISR as a potential adaptive survival pathway. Although ISRIB in vivo efficiently blocked ISR genes Ppp1r15a and 4E-BP1 (Supplementary Table 2 . Unprocessed original scans of blots are shown in Supplementary  Fig. 8 . Fig. 6f,g ), we did not observe reduced survival of intestinal cDC1s lacking XBP1 (Fig. 6f) . Thus, although intestinal cDC1s enduring ER stress mount an ISR, at present we have insufficient evidence to indicate that this pathway protects against ER stress-induced apoptosis ( Supplementary Fig. 6h ).
RIDD is differentially fine-tuned in XBP1-deficient cDC1s
Loss of XBP1 results in IRE1 hyperactivation, potentially triggering RIDD 9, 18 . As RIDD has been shown to promote cell death through caspase-2 and thioredoxin interacting protein (TXNIP) 46 , distinct RIDD activities in cDC1s might result in alternative cell fates across tissues. To report on IRE1 endonuclease activity in the face of XBP1 loss, we crossed ERAI mice with XBP1 DC mice. XBP1 loss hyperactivated the IRE1 endonuclease in cDC1s, resulting in increased VenusFP fluorescence (Fig. 7a) . Still, differences in endonuclease activity in cDC1 populations were preserved, with lung XBP1 DC cDC1s displaying lower VenusFP fluorescence when compared with intestinal counterparts (Fig. 7a) . Confirming the results obtained by the ERAI reporter mice, cDC1s residing in the intestine degraded RIDD mRNA targets Bloc1s1, Tapbp and Ergic3 more profoundly in the absence of XBP1 when compared with their lung counterparts (Fig. 7b) . Thus cDC1s from the intestine and lung mount different degrees of RIDD, suggesting that RIDD may determine cell fate when XBP1 is lost.
RIDD activity promotes survival of XBP1-deficient intestinal cDC1s
Next, we generated mice deficient in both XBP1 and RIDD by crossing XBP1 DC mice with Ern1 fl/fl mice that have loxP sites flanking exons 20 and 21 (ref. 47) (referred to as 'XBP1 /IRE1 trunc DC mice'). DCs from XBP1 /IRE1 trunc DC mice are deficient for XBP1 and harbour a truncated IRE1 isoform with preserved kinase function but crippled endonuclease activity 48 . Whereas IRE1 is upregulated in XBP1-deficient cDC1s (ref. 18 ), XBP1-deficient cells bearing a heterozygous deletion of IRE1 displayed both full-size and truncated IRE1 isoforms (Fig. 7c and Supplementary Fig. 8 ). Splenic cDC1s of XBP1 /IRE1 trunc DC mice only contained low levels of truncated IRE1 (Fig. 7c and Supplementary Fig. 8 ). Validating this strategy, RIDD targets Bloc1s1, Tapbp1 and Ergic3 were no longer degraded in the compound deficient intestinal cDC1s (Fig. 7b) . As predicted, the levels of IRE1 inversely correlated with CD11c expression, which can be used as a surrogate marker of RIDD activity (Fig. 7d) . Thus, genetic targeting of IRE1 endonuclease in XBP1 /IRE1 trunc DC mice allowed for subtle titration of RIDD activation in vivo (Fig. 7d) .
Subsequent analysis revealed that RIDD inhibition on top of XBP1 deficiency did not rescue lung cDC1s, arguing against a proapoptotic role for RIDD. On the contrary, lung and MedLN migratory cDC1 decreased further in mice with reduced or absent RIDD activity (Fig. 8a-c) . Removal of IRE1 on top of XBP1 deficiency reduced intestinal cDC1s in a gene-dosage-dependent manner, showing that RIDD was protective. This defect was even more pronounced in migratory cDC1s of the MesLN (Fig. 8d-f) . Compound loss of IRE1 and XBP1 had minimal effects on the cDC2 compartment in the lung ( Supplementary Fig. 7a-d ) and intestine ( Supplementary Fig. 7e-h) .
Although XBP1 /IRE1 trunc DC cDC1s still harbour a truncated IRE1, containing the kinase domain 48 , IRE1 levels in the compound deficient mice were markedly lower (Fig. 7c) . Therefore, we assessed the protective role of RIDD using B-I09, a known chemical inhibitor of the IRE1 endonuclease with in vivo applicability 49 . In cultured DCs derived from ERAI transgenic mice, the concomitant treatment with B-I09 at different doses (5 and 20 mM) inhibited tunicamycininduced VenusFP generation (Fig. 8g) . In vivo, B-I09 reduced VenusFP fluorescence in ERAI transgenic splenic cDC1s (Fig. 8h) and blocked Xbp1 mRNA splicing (Fig. 8i) . As the half-life of B-I09 is limited in vivo (Fig. 8i) , we evaluated the effects of B-I09 on cDC1 survival ex vivo. MesLNs, containing intestinal migratory cDC1s, were collected from Xbp1 fl/fl , XBP1 DC or XBP1 /IRE1 trunc DC mice. Single-cell suspensions were mixed with CD45.1 WT counterparts and cultured with B-I09 or vehicle control. B-I09 efficiently blocked RIDD and restored CD11c expression (Fig. 8j) . B-I09 specifically induced loss of XBP1 DC cDC1s, but not XBP1 fl/fl or XBP1 /IRE1 trunc DC cDC1s, confirming that inhibition of the IRE1 endonuclease is detrimental for cDC1s in the face of chronic ER stress due to XBP1 loss. B-I09 did not influence the survival of cDC2s (Fig. 8k) . Overall, these data suggest that IRE1-dependent RIDD activation alleviates the deleterious effects of XBP1 deficiency in cDC1s and protects against cell death (Supplementary Fig. 7i ). This effect is particularly pronounced in the intestine, explaining why these cells survive the loss of XBP1 (Fig. 8l) .
DISCUSSION
In recent years, our knowledge of the transcriptional pathways governing DC development and maintenance has expanded profoundly. cDC1s-involved in immune tolerance and antiviral and antitumour responses 15 -depend on Batf3, Irf8 and Id2 for development 50 . Additional proteins, such as Csf2rb (ref. 51) and MycL (ref. 52) , contribute to the maintenance of peripheral but not lymphoid tissue cDC1s. Here, we add XBP1, a major regulator of the UPR, to the growing list of factors involved in tissue-resident cDC1 homeostasis. Whereas loss of XBP1 did not affect splenic cDC1 survival, XBP1 appeared essential for peripheral-tissue-resident cDC1s. This was particularly prominent in lung cDC1s, but far less pronounced in the intestine.
Already at pre-cDC stage, pre-cDC1s could be identified by a marked increase in XBP1 splicing. Despite this enhanced splicing, XBP1 was not needed for cDC1 development. Rather, XBP1 maintained cellular health in terminally differentiated cDC1s. At first glance, this is in conflict with earlier reports claiming a role for XBP1 in the development of the whole DC compartment 19, 27 . Importantly, the transgenic strains used in those studies displayed a more widespread deletion of XBP1 in the haematopoietic system. Probably, XBP1 loss in early progenitor cells can account for the observed discrepancies, since our ERAI data indicate that XBP1 is also spliced at the common myeloid progenitor level.
In lung and intestine, cDC1s are exposed to ER stresses that do not differ sufficiently to explain the distinct cell fates upon loss of XBP1. Chronic ER stress and apoptosis are unequivocally linked, although the upstream mechanisms driving cell demise remain elusive 5 . Many studies investigating ER stress-induced cell death have identified CHOP as the main culprit driving apoptosis. In contrast to expectations, CHOP was clearly not involved in lung cDC1 cell death.
Adaptation to chronic ER stress is tightly coupled with translational control, to avoid excessive protein loading of the ER 34, 43, 53 . In the absence of XBP1, intestinal cDC1s reduce their translational rate in a P-eIF2α-and 4E-BP1-dependent manner, confirming earlier findings 42 . 4E-BP1, activated by ATF4 as part of the ISR, was more highly expressed in intestinal cDC1s when compared with lung cDC1s. 4E-BP1 functions to suppress translation in later stages of the UPR, when eIF2α-mediated control is turned off by the GADD34-negative feedback loop 38, 42 . In pancreatic B-cells, 4E-BP1 is part of an adaptive modus that protects against ER stress-induced cell death 43 .
In intestinal cDC1 cells, however, inhibition of the ISR did not cause cell death, indicating that adaptive responses and translational nodes controlled by P-eIF2α and ATF4 are likely to be complex and/or are not easily manipulated in vivo with current tools.
Moreover, IRE1 has been reported to mediate apoptosis in chronically ER stressed cells, in a both kinase-and endonucleasedependent manner. Overactivation of JNK and NF-κB by the IRE1 kinase is toxic for XBP1-deficient Paneth cells, and lowering IRE1 levels protects against cell death 25 . In our hands, however, higher levels of IRE1 in intestinal cDC1s were correlated with a protective phenotype in the absence of XBP1. This was linked not to JNK or NF-κB signalling, but rather to a differential capacity to engage RIDD 9, 10 . Loss of RIDD on top of XBP1 deficiency caused intestinal cDC1 demise, suggesting that a DC-intrinsic factor-IRE1-dependent RIDD activity-rather than local environmental factors determined the balance between life and death in XBP1-deficient cDC1s. Mann-Whitney test, * * P < 0.01. (k) Ratios of B-I09-treated over vehicletreated cDC1s and cDC2s derived from Xbp1 fl/fl (n = 2 mice), XBP1 DC (n = 9 mice) and XBP1 DC/IRE1 trunc DC MesLNs (n = 10 mice). Each dot represents an individual mouse. Mann-Whitney test, * * P < 0.01. Data are representative of one (g,i) or two (j) independent experiments or pooled across two (a-f,h,k) independent experiments. Source data for k can be found in Supplementary Table 2. (l) Summary of events on XBP1 deficiency in cDC1s. Loss of XBP1 in cDC1s activates both IRE1 and PERK. Whereas this is only modest in the lung, activation is pronounced in the intestine, resulting in inhibition of cell death in the intestine in a RIDD-dependent manner. Currently, it is unclear whether the PERK-mediated translational inhibition in the intestine contributes to cell survival.
So far, the physiological role of RIDD remains speculative. Revealed mostly during chronic ER stress or in conditions of XBP1 loss, RIDD is proposed to lower mRNA abundance and hence protein folding in the ER 9 . This implies a random degradation of ER-localized mRNAs, though in mammalian cells RIDD appears to be a highly selective process 54 . By selectively degrading particular microRNAs, IRE1 induces caspase-2 and/or thioredoxin interacting protein (TXNIP) expression, causing caspase-2-or caspase-1-mediated cell death 11, 12 . While this might be the case for fibroblasts, insulinomas, or kidney cell lines, we did not detect elevated levels of Casp2 or Txnip mRNA in XBP1-deficient cDC1s, illustrating the existence of celltype-specific RIDD targets. More recently, studies also reported a prosurvival role of RIDD, in which IRE1 degrades Tnfrsf10b mRNA, a proapoptotic target molecule activated by PERK and CHOP 55 . Representing another potential survival mechanism, RIDD regulates protein translation in XBP1-deficient hepatocytes by degrading Ppp1r15b mRNA, encoding for a phosphatase implicated in eIF2α dephosphorylation 56 . Irrespective of the mechanism, RIDD activation in cDC1s represents a pro-survival mechanism, underscoring the tissue-specific functions of RIDD.
Finally, we believe that our observations not only further our knowledge of cDC survival but also are relevant for understanding the functional specialization of tissue cDCs. All XBP1-deficient cDC1s-but not cDC2s-in lung, spleen and intestine, contained aggregated ER that seemed to invade the whole cytosol 18 . This aberrant ER and massive accumulation of lipid membranes might be the result of defective lipid handling due to XBP1 absence. As professional phagocytes of apoptotic corpses, this might be particularly relevant for cDC1s. Apoptotic cell uptake by XBP1-deficient cDC1s might cause lipotoxic stress, as reflected by the induction of Trib3. We speculate that in the intestine, where apoptotic cell turnover and lipotoxic stress are expected to be high, cDC1s have developed more elaborate strategies to cope with such stresses.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. 
B6.Tg
Itgax-cre1-1Reiz ) mice were bred at Ghent University in specific pathogenfree conditions.
To generate radiation chimaeras in C57BL/6 CD45.1/CD45.2 hosts, the BM of CD45.1 and XBP1 DC was used. In short, 12 h after lethal irradiation (8 Gy), CD45.1/2 mice were injected intravenously with 2 × 10 6 BM cells of a 1:1 mix derived from CD45.1 and CD45.2 XBP1 DC mice. Mice were used for experiments at least 8 weeks after reconstitution.
All mice, except the XBP1 DC-Chop null (F3 offspring of XBP1 DC and Chop null were used for experiments), were backcrossed at least five times to C57BL/6 background. All animal experiments were performed in accordance with institutional guidelines for animal care of the VIB site Ghent-Ghent University Faculty of Sciences. Litters with mice of both sexes at 6-14 weeks of age were used for experiments.
Preparation of cell suspensions. In the case of lung and spleen, organs were digested at 37 • C for 30-45 min in RPMI 1640 (61870036; Gibco) containing Liberase TM (0.02 mg ml −1 ; Roche) and DNase I recombinant (0.01 U ml −1 ; Roche) after mincing. The obtained cell suspension was cleared of red cells by osmotic lysis. In the case of intestinal tissue, epithelial cells were removed by serial washes at 37 • C with Hank's balanced salt solution without Ca 2+ or Mg 2+ (HBSS; Gibco) containing 10% FCS (Bodinko) and 2 mM EDTA (51234; Lonza). The lamina propria is subsequently digested at 37 • C for 15-20 min in RPMI 1640 supplemented with 10% FCS, collagenase VIII (0.66-1 mg ml −1 ; Sigma) and DNase I recombinant (0.01 U ml −1 ). Single-cell suspensions of BM are obtained by crushing of tibia and femur and subsequent lysis of red blood cells.
Flow cytometry and cell sorting. Monoclonal antibodies labelled with fluorochromes or biotin recognizing the following surface markers were used: CD3 (145-2C11; Tonbo; used 1/300), CD19 (1D3; Tonbo; used 1/500), CD45R (RA3-6B2; BD Pharmingen; used 1/200), TER119 (TER119; eBioscience; used 1/300), Ly6G (1A8; BD Pharmingen; used 1/500), CD64 (X54-5/7.1; BD Pharmingen; used 1/100), CD11c (N418; eBioscience; used 1/500), MHCII (M5/114.15.2; eBioscience; used 1/1,000), CD135 (A2F10; eBioscience; used 1/100), CD26 (H194-112; BioLegend; used 1/100), CD172a (P84; eBioscience; used 1/100), XCR1 (ZET; BioLegend; used 1/500), CD103 (2E7; eBioscience; used 1/200), CD86 (PO3; BioLegend; used 1/100), CD40 (3/23; BD Pharmingen; used 1/100), MHCI H-2b/d/p/q/w16 (ER-HR52; AbD Serotec; 1/200), CD45 (30-F11; eBioscience; 1/400), CD45.1 (A20; eBioscience; used 1/300), CD45.2 (104; eBioscience; used 1/300), Siglec-H (eBio440c; eBioscience; used 1/200), Ly6C (HK1.4; eBioscience; used 1/500), CD115 (AFS98; eBioscience; used 1/100), CD117 (2B8; eBioscience; used 1/1,000), CD11b (M1/70; BD Pharmingen; used 1/800), CD24 (M1/69; BD Pharmingen; used 1/500) and mPDCA1 (120g8; in-house manufactured; used 1/400). Viable cells were discriminated by the use of Fixable Viability Dye eFluor 506 or 786 (eBioscience; used 1/2,000). Acquisition and analysis of labelled cell suspensions was performed with an LSR Fortessa (BD Biosciences) and subsequent analysis of data with FlowJo10 software (FlowJo, LLC).
Cell sorting was performed on FACS ARIAII and III (BD Biosciences). In the case of the spleen and bone marrow, the single-cell suspension was enriched prior to cell sorting by depletion of CD3 + , CD19 + , Ly6G + , NK1.1 + , TER119 + and CD45R + cells using fluorescein isothiocyanate-labelled monoclonal antibodies recognizing CD3, CD19, Ly6G, NK1.1, TER119 and CD45R and anti-fluorescein isothiocyanate microbeads (130-048-701; Miltenyi Biotec).
Intracellular staining for IRE1, P-eIF2α, 4E-BP1, p4E-BP1 and DAP5 Cell suspensions were, after extracellular staining with antibody cocktail for surface markers, fixed at room temperature for 30 min and subsequently permeabilized with the FoxP3 staining kit (00-5523-00; eBioscience). Cells were labelled for 45 min at room temperature or on ice with the respective antibodies raised against IRE1 (H190; Santa Cruz; used 1/1,000), P-eIF2α (D9G8, Cell Signaling; used 1/200), 4E-BP1 (53H11, Cell Signaling; used 1/800), p4E-BP1 (236B4, Cell Signaling; used 1/50) and DAP5 (D88B6, Cell Signaling; used 1/200). After washing, the cells are incubated for 30 min on ice with an AlexaFluor-647 labelled goat anti-rabbit antibody (A2144; Invitrogen; used 1/4,000) or in the case of P-eIF2α with a BV786 fluorochrome conjugated to streptavidin (563858, BD Pharmingen).
Flt3L-supplemented cell cultures. Cells were cultured in RPMI 1640 medium supplemented with GlutaMAX, 2-mercaptoethanol, gentamicin (all from Gibco), 10% FCS and 250 ng ml −1 recombinant Flt3L (produced in-house).
Reagents. zVAD-fmk (N-1510.0005; Bachem) was resuspended in DMSO and used at a final concentration of 250 µM. ISRIB (SML0843-5MG; Sigma) was dissolved in DMSO (1 mg ml −1 ), mixed 1:1 in PEG400 (91893-250ML-F; Sigma) and injected intraperitoneally twice daily for 3 days at 2.5 mg kg −1 . CC-930 (HY-15495; MedchemExpress) was dissolved in DMSO at a concentration of 50 mg ml −1 ; a 12.5% solution was made in PEG400 and injected intraperitoneally daily (50 mg kg −1 ) for 5 days. Tunicamycin (T7765; Sigma) was dissolved in DMSO to a 10 mg ml −1 stock concentration and used at a concentration of 1 µg ml −1 in vitro. Cycloheximide was dissolved in DMSO (10 mg ml −1 ) and used at a concentration of 5 µg ml −1 in vitro. B-I09 (donated by Chih-Chi Andrew Hu) was dissolved at a concentration of 80 mM in DMSO and used in vitro at 20 µM, unless stated otherwise. In vivo, B-I09 was injected intraperitoneally at a final concentration of 0.625 mg/25 g mouse.
Measurement of BrdU incorporation. Mice were injected intraperitoneally with 100 µl of 10 mg ml −1 BrdU in Dulbecco's phosphate-buffered saline on day1. From day 1 to day 3, BrdU was added to the drinking water of mice at a final concentration of 0.5 mg ml −1 , protected from daylight. On day 4, mice were killed and organs collected. Single-cell suspensions were prepared and cells were stained with monoclonal antibody mixtures as described. After fixation and permeabilization, cell suspensions were treated with DNase to expose BrdU epitopes and stained with an APC-conjugated anti-BrdU antibody (B44; BD Biosciences; used 1/50) according to the manufacturer's protocol (552598; BD Biosciences).
Measurement of protein synthesis. OP-puro (NU-931-5; Jena Bioscience) was dissolved in DMSO, further diluted in PBS (10 mg ml −1 ) and injected intraperitoneally (50 mg/kg mouse weight). 1 h after injection mice were euthanized by cervical dislocation and the organs of interest were collected. 7 × 10 6 cells were stained with mixtures of antibodies directed against cell-surface markers. Each staining lasted approximately 30 min and was carried out on ice protected from direct light. Next, cells were fixed and permeabilized using the FoxP3 fixation/permeabilization kit (00-5521-00; eBioscience). For OP-puro labelling, azide-AF647 was chemically linked to OP-puro through a copper-catalysed azide-alkyne cycloaddition. In short, 2.5µM azide-AF647 (A10277; Invitrogen) is dissolved in Click-iT Cell Reaction Buffer (C10269; Invitrogen) containing 400 µM CuSO4. Immediately after preparation, cells are incubated with this mixture at room temperature. After 10 min incubation, the reaction is quenched by addition of PBS supplemented with 5% heat-inactivated FCS and 5 mM EDTA. Cells are washed twice to remove unbound azide-AF647. (Adapted from ref. 36.) Immunoblotting. Sorted DCs (2 × 10 5 ) were spun at 400g for 7 min. After sorting, the supernatant was removed and the pellet resuspended in ice-cold PBS and transferred to a 1.5 ml reaction tube. After a next round of centrifugation (400g , 7 min), the pellet was pipetted dry and resuspended in 30 µl of E1A buffer (1% NP40, 20 mM HEPES, pH 7.9, 250 mM NaCl, 1 mM EDTA) complemented with Complete-ULTRA (05 892 970 001; Roche) and PhosSTOP (04 906 837 001; Roche). Lysates were snap-frozen in liquid nitrogen and stored at −80 • C until further use. Prior to SDS-PAGE, samples were spun at 12,000g to remove insoluble material and were resuspended in 10 µl of loading dye. After wet transfer to polyvinyldifluoride membrane (Immobilon; Millipore), proteins were analysed by immunoblotting and visualized by chemiluminescence (NEL 104001EA; Perkin Elmer). Antibodies used recognize IRE1 (14C10; Cell Signaling; used 1/1,000) and HSP-90 (H114; Santa Cruz; used 1/400), phospho-JNK (9251s; Cell Signaling; used 1/1,000), JNK (9258s; Cell Signaling; used 1/1,000) and β-tubulin (ab21058; Abcam; used 1/5,000).
RNA isolation, qrtPCR and primers. DCs (2-3.5 × 10 4 ) were sorted directly into RLT Plus-buffer (1048449; Qiagen) and stored at −80 • C until further processing. RNA was obtained using the RNeasy Plus Micro Kit (74034; Qiagen) following manufacturer's instructions. Integrity and concentration of RNA were assessed using Agilent RNA Pico chips and Bioanalyzer (5067-1513; Agilent). Complementary DNA was amplified using the Ovation PicoSL WTA System V2 kit (3312-24; NuGEN) according to the manufacturer's guidelines. Pollutants were removed using the MinElute PCR purification kit (28204; Qiagen) prior to SYBR Green-based qrtPCR (Lightcycler 480, Roche). mRNA expression was analysed using qbase+ software version 2.6 (Biogazelle). All primer sequences can be retrieved in Supplementary Table 1 .
Immunocytochemistry. DCs (6-8 × 10 4 ) were seeded on fibronectin-coated Ibidi eight-well chambers and left to adhere for 1 h at 37 • C. Cells were rinsed with PBS, fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton-X-100, blocked with 0.2% normal donkey serum and stained overnight with KDEL, an ER marker 
